Europe Approves AstraZeneca's Imfinzi (Durvalumab) Combined With FLOT Chemotherapy For Resectable, Early-Stage, And Locally Advanced Gastric And Gastroesophageal Junction Cancers - AstraZeneca (NYSE:AZN)
Published on March 16, 2026.
The European Parliament has approved the use of a drug called "Norfolk", a form of formaldehyde. The drug manufacturer behind the wheel is set to use this drug in a bid to combat cancer. However, the legal implications for the drug are unclear. The company has been criticised for its use of the drug, which is currently being investigated by the National Association of Health and Prevention (NHS), and for its effectiveness in combating cancer.
Related Articles
In The Age Of AI, Your LinkedIn Profile Is Only Half Your Brand
LinkedIn, now a crucial platform for professional branding, has evolved significantly due to its ability to create and maintain credible, trustworthy profiles using AI-generated content.
Brazil Q4 Earnings Hit Record Lows on Beat Rates as Selic Bites
Brazil Q4 earnings experienced record lows due to high Selic rates, but stable investor confidence and macro factors remain in place.
Google Shares More Information On Googlebot Crawl Limits
Google’s Gary Ilyes and Martin Splitt discussed the flexibility and complexity of Googlebot’S crawl limits, highlighting multiple settings and internal controls to protect infrastructure from overwhelming data.